https://www.igm.cnr.it/laminopatie/wp-content/uploads/2020/09/icona-pub.png150150lampresshttps://www.igm.cnr.it/laminopatie/wp-content/uploads/2023/08/Top_Lamino_2023.pnglampress2021-09-23 14:33:262022-01-03 09:57:15Inhibition of the NLRP3 inflammasome improves lifespan in animal murine model of Hutchinson-Gilford Progeria.
https://www.igm.cnr.it/laminopatie/wp-content/uploads/2020/09/icona-pub.png150150lampresshttps://www.igm.cnr.it/laminopatie/wp-content/uploads/2023/08/Top_Lamino_2023.pnglampress2021-09-23 14:13:072022-01-03 09:58:38Genetic reduction of mTOR extends lifespan in a mouse model of Hutchinson-Gilford Progeria syndrome
https://www.igm.cnr.it/laminopatie/wp-content/uploads/2020/09/icona-pub.png150150lampresshttps://www.igm.cnr.it/laminopatie/wp-content/uploads/2023/08/Top_Lamino_2023.pnglampress2021-09-22 09:23:392021-09-22 09:25:54Lonafarnib: First Approval
